as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 25 Sep 2026
₹582.6
Change
-0.35 (-0.06%)
Open
₹584.95
Prev. Close
₹582.95
Day High
₹589.95
Day Low
₹572.1
Volume Analysis
Traded
130,509
Delivered
71,991
Delivery %
55.16%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (1)
- •Strong operating margin (25.0%)
Weaknesses (1)
- •Promoter holding is falling
Opportunities (0)
No signal for this stock
Threats (1)
- •FII holding has been falling
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹608.85 | ₹599.4 | ₹591.0 | ₹581.55 | ₹573.15 | ₹563.7 | ₹555.3 |
| Fibonacci | ₹599.4 | ₹592.58 | ₹588.37 | ₹581.55 | ₹574.73 | ₹570.52 | ₹563.7 |
| Camarilla | ₹587.51 | ₹585.87 | ₹584.24 | ₹581.55 | ₹580.96 | ₹579.33 | ₹577.69 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-69.29%
1 Week
-1.82%
1 Month
-0.99%
3 Months
+7.86%
6 Months
+37.32%
1 Year
-71.08%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹122.73
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
12.89%
Net margin 11.87% × asset turnover 0.77x × equity multiplier 1.41x
Company Overview
Sector
Healthcare
Market Cap
₹12,086 Cr
P/E (TTM)
58.1
ROE
13.6%
Book Value
₹73.0
Face Value
₹2.0
Source: Screener.in (Consolidated figures) — data as of 26 Sep 2026. Not investment advice.
TopFund Analysis
Metropolis Healthcare Ltd holds up reasonably well on TopFund's composite fundamentals check within the Healthcare sector, at 65/100. The strongest factor is Financial Strength (100/100), while Valuation (1/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (25.0%); promoter holding is falling. FII holding has been falling.
TopFund Score — Fundamentals Quality
65/100 — GoodData confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 27 Sep 2026 · How we calculate this →
Financial Strength
Growth
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- −Stock is trading at 7.98 times its book value
- −The company has delivered a poor sales growth of 10.5% over past five years.
- −Company has a low return on equity of 12.4% over last 3 years.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
Allotment of 66,312 equity shares under the Metropolis- Restrictive Stock Unit Plan, 2020
MQSPL signed SSA and SHA with Medsource and Dr. Puneet; total investment about INR 1.26 crore.
Transcript of Investors & Analyst Meet held on Thursday, August 27, 2026
Audio recording of Investors & Analyst Meet held on August 27, 2026 uploaded on company website.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 277 | 308 | 291 | 331 | 313 | 350 | 323 | 345 | 386 | 429 | 406 | 425 | 450 |
| Expenses + | 214 | 234 | 226 | 251 | 235 | 260 | 251 | 283 | 296 | 321 | 311 | 317 | 339 |
| Operating Profit | 63 | 75 | 65 | 80 | 79 | 90 | 72 | 62 | 90 | 108 | 95 | 108 | 111 |
| OPM % | 23.0% | 24.0% | 22.0% | 24.0% | 25.0% | 26.0% | 22.0% | 18.0% | 23.0% | 25.0% | 23.0% | 25.0% | 25.0% |
| Other Income + | 3 | 1 | 2 | 3 | 2 | 3 | 3 | 7 | 8 | 1 | 0 | 8 | 5 |
| Interest | 6 | 6 | 5 | 6 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 8 | 6 |
| Depreciation | 21 | 22 | 25 | 26 | 26 | 27 | 28 | 29 | 31 | 32 | 32 | 39 | 32 |
| Profit before tax | 39 | 48 | 37 | 51 | 51 | 61 | 42 | 36 | 61 | 71 | 57 | 70 | 78 |
| Tax % | 26.0% | 26.0% | 26.0% | 28.0% | 25.0% | 24.0% | 26.0% | 19.0% | 26.0% | 26.0% | 26.0% | 27.0% | 27.0% |
| Net Profit + | 29 | 36 | 27 | 37 | 38 | 47 | 31 | 29 | 45 | 53 | 42 | 51 | 57 |
| EPS in Rs | 1 | 2 | 1 | 2 | 2 | 2 | 2 | 1 | 2 | 3 | 2 | 2 | 3 |
| Raw PDF | — | — | — | — | — | — | — | — | — | — | — | — | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 456 | 475 | 545 | 647 | 761 | 856 | 998 | 1,228 | 1,148 | 1,208 | 1,331 | 1,646 | 1,710 |
| Expenses + | 339 | 359 | 405 | 467 | 559 | 619 | 708 | 880 | 855 | 920 | 1,023 | 1,240 | 1,288 |
| Operating Profit | 117 | 116 | 140 | 181 | 203 | 237 | 290 | 348 | 293 | 288 | 308 | 406 | 422 |
| OPM % | 26.0% | 24.0% | 26.0% | 28.0% | 27.0% | 28.0% | 29.0% | 28.0% | 26.0% | 24.0% | 23.0% | 25.0% | 25.0% |
| Other Income + | 7 | 29 | 39 | 6 | 8 | -17 | 12 | 34 | 15 | 9 | 15 | 16 | 14 |
| Interest | 2 | 2 | 2 | 4 | 4 | 13 | 12 | 25 | 32 | 28 | 24 | 29 | 26 |
| Depreciation | 21 | 17 | 17 | 19 | 20 | 39 | 46 | 63 | 89 | 94 | 109 | 134 | 135 |
| Profit before tax | 101 | 128 | 160 | 164 | 187 | 169 | 244 | 293 | 188 | 175 | 191 | 259 | 276 |
| Tax % | 33.0% | 36.0% | 33.0% | 32.0% | 34.0% | 24.0% | 25.0% | 27.0% | 24.0% | 26.0% | 24.0% | 26.0% | — |
| Net Profit + | 68 | 82 | 107 | 112 | 124 | 128 | 183 | 215 | 143 | 128 | 146 | 191 | 203 |
| EPS in Rs | 15 | 20 | 27 | 27 | 6 | 6 | 9 | 10 | 7 | 6 | 7 | 9 | 10 |
| Dividend Payout % | 0.0% | 100.0% | 49.0% | 0.0% | 55.0% | 32.0% | 22.0% | 19.0% | 29.0% | 16.0% | 0.0% | 55.0% | — |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reserves | 352 | 269 | 314 | 405 | 408 | 513 | 696 | 876 | 978 | 1,086 | 1,321 | 1,472 |
| Borrowings + | 14 | 5 | 1 | 1 | 18 | 67 | 112 | 379 | 266 | 197 | 204 | 232 |
| Other Liabilities + | 87 | 107 | 188 | 110 | 113 | 160 | 181 | 256 | 240 | 254 | 324 | 386 |
| Total Liabilities | 462 | 391 | 512 | 526 | 550 | 750 | 1,000 | 1,521 | 1,495 | 1,547 | 1,859 | 2,131 |
| Fixed Assets + | 153 | 142 | 202 | 207 | 213 | 296 | 343 | 1,059 | 1,121 | 1,177 | 1,447 | 1,601 |
| CWIP | 0 | 1 | 1 | 0 | 6 | 3 | 0 | 6 | 20 | 0 | 0 | 0 |
| Investments | 168 | 101 | 142 | 102 | 33 | 14 | 10 | 16 | 15 | 55 | 71 | 142 |
| Other Assets + | 141 | 147 | 167 | 216 | 298 | 437 | 647 | 440 | 340 | 316 | 341 | 387 |
| Total Assets | 462 | 391 | 512 | 526 | 550 | 750 | 1,000 | 1,521 | 1,495 | 1,547 | 1,859 | 2,131 |
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 41 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 69 | 91 | 102 | 104 | 90 | 215 | 249 | 253 | 247 | 264 | 263 | 351 |
| Cash from Investing Activity + | -56 | 96 | -86 | 1 | 36 | -104 | 63 | -736 | 48 | -89 | -199 | -220 |
| Cash from Financing Activity + | -9 | -174 | -17 | -87 | -118 | -55 | -33 | 163 | -292 | -181 | -87 | -115 |
| Net Cash Flow | 4 | 14 | -1 | 18 | 8 | 56 | 279 | -321 | 3 | -6 | -23 | 15 |
| CFO/OP | 87 | 113 | 109 | 89 | 78 | 118 | 106 | 96 | 102 | 105 | 99 | 98 |
| Free Cash Flow | 46 | 79 | 45 | 90 | 67 | 179 | 221 | 223 | 195 | 200 | 196 | 300 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 9.1% | 7.87% | 6.57% | 4.69% | 3.98% | 3.86% | 5.51% | 5.87% | 5.48% | 4.69% | 4.92% | 5.0% |
| Promoters | 49.75% | 49.74% | 49.67% | 49.62% | 49.43% | 49.4% | 48.89% | 48.89% | 48.89% | 48.87% | 48.86% | 48.86% |
| FII | 24.29% | 21.66% | 18.9% | 18.25% | 18.56% | 16.73% | 15.29% | 12.83% | 12.52% | 11.68% | 10.43% | 11.03% |
| DII | 16.86% | 20.73% | 24.86% | 27.42% | 28.02% | 30.0% | 30.3% | 32.4% | 33.1% | 34.73% | 35.8% | 35.12% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Healthcare — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Metropolis Healthcare Ltd (this stock) | 12,086 | 58.1 | 7.99 | 13.6% |
| Park Medi World Limited | 12,368 | 44.5 | 6.11 | 16.8% |
| Akums Drugs And Pharma L | 12,869 | 42.2 | 3.88 | 8.45% |
| Blue Jet Healthcare Ltd | 11,040 | 78.3 | — | 52.1% |
| Sudeep Pharma Limited | 13,157 | 72.0 | 14.9 | 25.2% |
| Corona Remedies Limited | 13,219 | 62.3 | 17.73 | 29.5% |
| Strides Pharma Sci Ltd | 10,922 | 18.8 | 3.52 | 20.0% |
Which Mutual Funds Hold Metropolis Healthcare Ltd?
Frequently Asked Questions about Metropolis Healthcare Ltd
Metropolis Healthcare Ltd (METROPOLIS) closed at ₹582.6 on NSE on 25 September 2026, down 0.35 (0.06%) from the previous close.
Metropolis Healthcare Ltd trades on the NSE (National Stock Exchange of India) under the symbol METROPOLIS.
Metropolis Healthcare Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 58.1.
Metropolis Healthcare Ltd has a dividend yield of 0.34%.
Metropolis Healthcare Ltd's 52-week high is ₹609.0 and its 52-week low is ₹412.0.
Metropolis Healthcare Ltd has a market capitalisation of ₹12,086 crore.
Metropolis Healthcare Ltd has a TopFund Quality Score of 65/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Metropolis Healthcare Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.